01/21/22 |
NIH |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
04/03/20 |
NIH |
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) |
Link |
NIH |
Due dates may vary by awarding IC. See Table of IC-Specific Information, Requi… |
04/08/22 |
NIH |
Notice of Special Interest (NOSI): Technological Innovations for Advancing Clinical SPECT Imaging |
Link |
NIH NOSI |
Application due: 05/08/24 |
02/27/20 |
NIH |
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
04/30/20 |
NIH |
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
Link |
NIH |
Due dates vary by awarding IC |
09/22/22 |
NIH |
Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech |
Link |
NOSI |
|
03/06/19 |
NIH |
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
07/23/20 |
NIH |
PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
05/31/18 |
NIH |
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional) |
Link |
NIH |
Standard dates apply |
05/20/22 |
NIH |
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/28/20 |
NIH |
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
Link |
NIH |
Submission dates vary by awarding IC |
08/08/19 |
NIH |
Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21) |
Link |
NIH |
Standard due dates apply |
05/14/21 |
NIH |
Notice of Special Interest: Public Policy Effects on Alcohol-, Cannabis-, Tobacco-, and Other Drug-Related Behaviors and Outcomes |
Link |
NIH |
Application due: 09/08/24 |
11/22/19 |
NIH |
Addressing Health Disparities through Effective Interventions among Immigrant Populations (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
10/16/19 |
NIH |
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2018, 2019, and 2020 (P50 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
12/14/21 |
NIH |
Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research |
Link |
NIH NOSI |
Application due: 01/08/25 |
12/07/18 |
NIH |
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R21/R33 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
01/11/19 |
NIH |
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R21) |
Link |
NIH |
Standard due dates apply |
04/17/20 |
NIH |
Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 |
Link |
NIH COVID-19 |
|
07/22/22 |
NIH |
Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan |
Link |
NIH NOSI |
Application due: 05/08/25 |
02/17/19 |
NIH |
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42) |
Link |
NIH |
Standard due dates apply |
07/23/20 |
NIH |
Symptom Cluster Characterization in Chronic Conditions (R01) |
Link |
NIH |
Standard due dates apply |
05/22/18 |
NIH |
Metabolic Reprogramming to Improve Immunotherapy (R01) |
Link |
Research |
Standard due dates apply |
02/14/23 |
NIH |
Notice of Special Interest (NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective Interventions |
Link |
NIH NOSI |
Application due: 06/06/26 |
05/06/19 |
NIH |
Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21) |
Link |
NIH |
Standard due dates apply |
07/23/20 |
NIH |
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard dates |
11/22/19 |
NIH |
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
11/30/18 |
NIH |
Examination of Survivorship Care Planning Efficacy and Impact (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/22/22 |
NIH |
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
02/17/19 |
NIH |
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
11/13/20 |
NIH |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) |
Link |
NIH |
Standard due dates apply |
11/08/20 |
NIH |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) |
Link |
NIH |
Standard due dates apply |
07/17/19 |
NIH |
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) |
Link |
NIH |
|
04/02/21 |
NIH |
Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
11/22/19 |
NIH |
Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
09/19/19 |
NIH |
Revision Applications for Mechanisms of Cancer Drug Resistance (R01 Clinical Trial Not Allowed) |
Link |
NIH |
|
11/30/18 |
NIH |
Mentored Patient-Oriented Research Career Development Award (Parent K23 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
02/14/20 |
NIH |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) |
Link |
NIH |
Standard due dates apply |
02/14/20 |
NIH |
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
06/17/22 |
NIH |
Notice of Special Interest (NOSI): Availability of Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
Link |
NIH NOSI |
Application due: 06/02/25 |
05/29/20 |
NIH |
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
04/18/19 |
NIH |
Tailoring Dental Treatment for Individuals with Systemic Diseases that Compromise Oral Health (R01) |
Link |
NIH |
Standard due dates apply |
08/19/22 |
NIH |
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 06/10/24 |
07/20/18 |
NIH |
Postbac IRTA program (CRTA, Cancer Research Training Award, in the National Cancer Institute) |
Link |
Fellowship |
|
06/10/20 |
NIH |
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply - Note new SBIR/STTR Standard Due Dates. |
11/02/18 |
NIH |
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed) |
Link |
NIH |
Standard dates apply |
10/19/23 |
NIH |
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers |
Link |
NIH NOSI |
Application due: 07/02/25 |
11/21/18 |
NIH |
Metabolic Reprogramming to Improve Immunotherapy (R21) |
Link |
NIH |
Standard due dates apply |
03/18/22 |
NIH |
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
10/07/22 |
NIH |
Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
Link |
NOSI |
|
05/22/20 |
NIH |
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
07/18/18 |
NIH |
Gene Fusions in Pediatric Sarcomas (R21) |
Link |
NIH |
Standard dates apply |
03/01/21 |
NIH |
Tobacco Regulatory Science (R01 Clinical Trial Optional) |
Link |
NIH |
|
11/27/19 |
NIH |
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) |
Link |
NIH |
Standard dates apply |
08/13/20 |
NIH |
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/21/18 |
NIH |
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
12/06/19 |
NIH |
Co-infection and Cancer (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
12/17/19 |
NIH |
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
04/17/20 |
NIH |
Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars |
Link |
NIH |
Application due: 10/01/25 |
01/25/19 |
NIH |
Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/10/20 |
NIH |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) |
Link |
NIH |
Standard due dates apply |
05/25/19 |
NIH |
The Role of Mobile Genetic Elements in Cancer (R01) |
Link |
NIH |
Standard due dates apply |
10/19/18 |
NIH |
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21) |
Link |
NIH |
Standard AIDS dates apply |
07/23/20 |
NIH |
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
08/13/21 |
NIH |
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/21/18 |
NIH |
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/08/19 |
NIH |
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
01/21/22 |
NIH |
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
12/07/18 |
NIH |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
04/10/20 |
NIH |
Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
02/14/20 |
NIH |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
09/22/22 |
NIH |
Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) |
Link |
NOSI |
|
03/18/21 |
NIH |
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/31/20 |
NIH |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
05/25/19 |
NIH |
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R21) |
Link |
NIH |
Standard due dates apply |
11/30/20 |
NIH |
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) |
Link |
NIH |
Standard AIDS dates apply |
08/19/21 |
NIH |
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) |
Link |
NIH |
Standard dates apply |
08/08/19 |
NIH |
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01) |
Link |
NIH |
Standard due dates apply |
06/04/21 |
NIH |
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required) |
Link |
NIH |
Application due: 05/08/24 |
11/22/19 |
NIH |
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |